Rankings
▼
Calendar
NUVL FY 2019 Earnings — Nuvalent, Inc. Revenue & Financial Results | Market Cap Arena
NUVL
Nuvalent, Inc.
$7B
FY 2019 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$10M
Net Income
-$12M
EPS (Diluted)
$-0.24
Cash Flow
Operating Cash Flow
-$10M
Free Cash Flow
-$10M
Stock-Based Comp.
$41,000
Balance Sheet
Total Assets
$3M
Total Liabilities
$21M
Stockholders' Equity
-$17M
Cash & Equivalents
$3M
← Q1 2020
All Quarters
